OverviewSuggest Edit

Cochlear is a company developing implantable hearing solutions. Its products aim to treat hearing loss. 
TypePublic
Founded1982
HQMacquarie Park, AU
Websitecochlear.com
Employee Ratings3.4

Latest Updates

Employees (est.) (Apr 2022)4,000
Job Openings59
Revenue (FY, 2021)$1.5 B(+11%)
Share Price (May 2022)$216.5(-1%)
Cybersecurity ratingBMore
Discover new suppliers and conduct deeper comparison analysis with Craft for EnterpriseLearn more
Banner background

Cochlear Office Locations

Cochlear has offices in Macquarie Park, Centennial, Mechelen, Toronto and in 12 other locations
Macquarie Park, AU (HQ)
1 University Ave
Mechelen, BE
Schaliënhoevedreef 20j
Toronto, CA
2500-120 Adelaide St W
Bogotá, CO
Ak. 9 #11530
Toulouse, FR
135 Route de Saint-Simon
Hannover, DE
Karl-Wiechert-Allee 76A
Show all (21)

Cochlear Financials and Metrics

Cochlear Revenue

Cochlear's revenue was reported to be $1.49 b in FY, 2021
AUD

Revenue (H1, 2022)

820.7m

Gross profit (H1, 2022)

618.7m

Net income (H1, 2022)

169.3m

EBITDA (H1, 2022)

218.2m

EBIT (H1, 2022)

218.2m

Market capitalization (9-May-2022)

14.2b

Closing stock price (9-May-2022)

216.5

Cash (31-Dec-2021)

553.1m

EV

13.7b
Cochlear's current market capitalization is $14.2 b.
Annual
AUDFY, 2018FY, 2019FY, 2020FY, 2021

Revenue

1.4b1.4b1.4b1.5b

Cost of goods sold

(361.2m)(351.1m)(266.9m)(330.7m)

Gross profit

1.0b1.1b1.1b1.2b

R&D expense

(167.7m)(184.4m)(185.1m)(195.0m)
Half Year
AUDH1, 2019H1, 2020H1, 2021H1, 2022

Revenue

711.9m777.6m743.2m820.7m

Cost of goods sold

(179.5m)(192.2m)(209.2m)(207.7m)

Gross profit

540.3m595.5m562.0m618.7m

R&D expense

(88.2m)(94.4m)(88.4m)(98.6m)
Annual
AUDFY, 2018FY, 2019FY, 2020FY, 2021

Cash

61.5m78.6m565.0m609.6m

Accounts Receivable

299.1m299.5m211.4m262.1m

Prepaid Expenses

34.9m39.1m87.0m90.4m

Inventories

167.4m195.4m223.8m216.1m
Half Year
AUDH1, 2019H1, 2020H1, 2021H1, 2022

Cash

92.3m89.4m587.7m553.1m

Accounts Receivable

293.8m317.0m242.6m317.7m

Prepaid Expenses

41.0m38.5m113.0m83.6m

Inventories

176.5m204.0m196.8m238.0m
Annual
AUDFY, 2018FY, 2019FY, 2020FY, 2021

Net Income

245.8m276.7m(238.3m)326.5m

Depreciation and Amortization

34.2m38.5m77.5m79.5m

Inventories

(7.4m)(28.0m)(28.4m)7.7m

Accounts Payable

3.8m34.6m(30.3m)30.7m
Half Year
AUDH1, 2019H1, 2020H1, 2021H1, 2022

Net Income

128.6m157.7m236.2m169.3m
Show all financial metrics

Cochlear Revenue Breakdown

Embed Graph

Cochlear revenue breakdown by business segment: 100.0% from EAR IMPLANT INDUSTRY

Cochlear Cybersecurity Score

Cybersecurity ratingPremium dataset

B

84/100

SecurityScorecard logo

Cochlear Environment, Social & Governance (ESG) Ratings

CSRHub ESG ratingPremium dataset

50-59

out of 100

CSRHub logo

Cochlear Online and Social Media Presence

Embed Graph

Cochlear News and Updates

Cochlear backs medtech startup EpiMinder in $16 million bridge funding round

Melbourne-based epilepsy monitoring startup Epi-Minder has raised $16 million  bridge financing round. The raise was backed by existing shareholders including Cochlear, the Bionics Institute, the University of Melbourne and Seer Medical, as well as private investors. The venture plans to use the cas…

Cochlear Implants Market Size is Expected to Hit US$ 3.9 Bn by 2027 | AllTheResearch

Global “Cochlear Implants Market by Type (Bilateral Implant, Unilateral Implant); by End- Users (Children, Adults); and by Region (North America, Europe, Asia Pacific, Latin America, MEA); - Global Forecasts 2021 to 2027” Updated report added by AllTheResearch provides comprehensive coverage on majo…

iotaMotion Announces FDA Grants De Novo Request to Market The iotaSOFT™ Insertion System, First of Its Kind Robotic-Assisted Cochlear Implant Insertion System

IOWA CITY, Iowa, Oct. 5, 2021 /PRNewswire/ -- iotaMotion Inc., a leader in developing advanced surgical systems for cochlear implant surgery, announced FDA granted its' De Novo classification request to market the iotaSOFT™ insertion system. iotaSOFT is the world's first and only...

Global Cochlear Implant Market Report 2021 - Rising Adoption of Advanced Cochlear Implants for Children - Forecast to 2026

Dublin, Sept. 15, 2021 (GLOBE NEWSWIRE) -- The "Cochlear Implant Market - Forecasts from 2021 to 2026" report has been added to ResearchAndMarkets.com's offering. The global cochlear implant market is evaluated at US$2.071 billion for the year 2019 growing at a CAGR of 9.82% reaching the market si…

Highland Park Audiologist Adds Cochlear Implant Expert to Staff

HIGHLAND PARK, N.J., Aug. 11, 2021 /PRNewswire/ -- Dr. Tran Do has joined the staff of New Jersey audiology practice The Hearing Center, after completing a residency with a focus on cochlear implant patients. "Dr. Do brings empathy and compassion to her patients," said Dr. Eric Sandler,...
Show more

Cochlear Frequently Asked Questions

  • When was Cochlear founded?

    Cochlear was founded in 1982.

  • How many employees does Cochlear have?

    Cochlear has 4,000 employees.

  • What is Cochlear revenue?

    Latest Cochlear annual revenue is $1.5 b.

  • What is Cochlear revenue per employee?

    Latest Cochlear revenue per employee is $373.3 k.

  • Who are Cochlear competitors?

    Competitors of Cochlear include INTEGRA Biosciences, Dynatronics and Sagent Pharmaceuticals.

  • Where is Cochlear headquarters?

    Cochlear headquarters is located at 1 University Ave, Macquarie Park.

  • Where are Cochlear offices?

    Cochlear has offices in Macquarie Park, Centennial, Mechelen, Toronto and in 12 other locations.

  • How many offices does Cochlear have?

    Cochlear has 21 offices.